Company Profile
Updated: 28-OCT-09Pevion Biotech AG
Non-Quoted Public Company
Worblentalstrasse 32, Ittigen-Bern, CH-3063, Switzerland
()41 031 550 44 44, 41 031 550 44 45 fax, http://www.pevion.com/
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: A privately-owned Swiss biopharmaceutical company focusing on the preclinical and clinical development of vaccines to prevent/treat infectious diseases and cancer. For its vaccine development, the company uses a virosome technology which is already validated by two registered and marketed vaccines. The combination of this virosome technology with novel innovative antigens substantially reduces the known risk in biotechnological development and permits the targeting of diseases where so far no appropriate treatment is available. Pevion Biotech targets indications which represent major medical needs, including prophylactic or therapeutic vaccines against breast cancer, candidiasis, RSV, malaria and hepatitis C
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Pevion Gets $29M For Vaccine Pipeline.
BIOWORLD Today; 11/3/2009; 982 words; ...Today Correspondent Pevion Biotech AG raised CHF35 million...Switzerland-based BZ Bank AG led the funding transaction...participants included BB Biotech Ventures II LP...Asset Management AG, and CC Private Equity Partners Ltd. Pevion will receive its...
Mymetics Corporation - Financial and Strategic Analysis Review.
M2 Presswire; 5/4/2009; 800 words; ...oncoviral leukemias, multiple sclerosis and organ transplantation. The company employs virosome technology which is Pevion Biotech AG's proprietary technology for HIV and malaria vaccine. The company is headquartered in Nyon, Switzerland and employs...
WIPO: Inventors in Switzerland Develop Virosome
US Fed News Service, Including US State News; 2/4/2009; 385 words; ...have developed virosomes comprising hemagglutinin derived from an influenza virus. The patent has been assigned to Pevion Biotech AG, Bern, Switzerland. According to an abstract posted by the World Intellectual Property Organization, the present...
Other News To Note.
BIOWORLD Today; 12/17/2008; 1521 words; ...Europe will be required. Geneart AG, of Regensburg, Germany, and its DNA engineering partner, MorphoSys AG, of Martinsried, Germany, said...Biotechnology Corp., of Toronto, and Pevion Biotech Ltd., of Bern, Switzerland, agreed...
Mymetics Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech AG (Switzerland).
Business Wire; 5/19/2008; 1396 words; ...preventive malaria vaccine from Pevion Biotech AG, a privately-held biotech company based in Switzerland. The Pevion vaccine has successfully completed...a technology licensed from Pevion Biotech. Mymetics' vaccine approach...
Recent News Articles
- Mymetics Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech AG (Switzerland).
Business Wire - May 19, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning